Technical Analysis for BLPH - Bellerophon Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.6497 -3.56% -0.02
BLPH closed down 3.56 percent on Monday, May 20, 2019, on 2.16 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BLPH trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish -3.56%
50 DMA Support Bullish -3.56%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.56%
Bollinger Band Squeeze Range Contraction -3.56%
Upper Bollinger Band Walk Strength -3.56%

Older signals for BLPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Bellerophon Therapeutics LLC, a clinical-stage therapeutics company, focuses on the development of various products for the treatment of cardiopulmonary and cardiac diseases. Its product candidates include INOpulse for the treatment of pulmonary arterial hypertension, as well as to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics LLC in January 2014. Bellerophon Therapeutics LLC was founded in 2009 and is based in Hampton, New Jersey.
Cardiovascular Diseases Anatomy Pulmonary Arterial Hypertension Heart Failure Hypertension Cardiovascular System Aging Associated Diseases Pulmonary Hypertension Pulmonology Chronic Obstructive Pulmonary Diseases Congestive Heart Failure Respiratory Disease
Is BLPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.3
52 Week Low 0.47
Average Volume 270,279
200-Day Moving Average 0.8545
50-Day Moving Average 0.6611
20-Day Moving Average 0.6451
10-Day Moving Average 0.659
Average True Range 0.04
ADX 10.0
+DI 17.919
-DI 17.4549
Chandelier Exit (Long, 3 ATRs ) 0.5798
Chandelier Exit (Short, 3 ATRs ) 0.7255
Upper Bollinger Band 0.6839
Lower Bollinger Band 0.6063
Percent B (%b) 0.56
BandWidth 12.029143
MACD Line 0.0023
MACD Signal Line -0.0017
MACD Histogram 0.004
Fundamentals Value
Market Cap 23.07 Million
Num Shares 35.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -0.47
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.75
Resistance 3 (R3) 0.75 0.72 0.74
Resistance 2 (R2) 0.72 0.70 0.72 0.73
Resistance 1 (R1) 0.69 0.68 0.67 0.68 0.72
Pivot Point 0.65 0.65 0.64 0.65 0.65
Support 1 (S1) 0.62 0.63 0.60 0.62 0.58
Support 2 (S2) 0.58 0.61 0.58 0.57
Support 3 (S3) 0.55 0.58 0.56
Support 4 (S4) 0.55